Eurofins’ US Transplant Diagnostics and Cleveland Clinic Sign a Licensing Agreement to Expand Access to an Innovative, Novel Biomarker for Detecting Rejection in Kidney Transplant Patients

LEE'S SUMMIT, Mo., Feb. 8, 2021 /PRNewswire/ -- Eurofins Viracor, a leading infectious disease, immunology, and allergy diagnostics company focused on advancing diagnostic tests for transplant patients, announced today that it
by Transplant News